Calum B McFarlane

Title: Calum B McFarlane: Innovator in Pharmaceutical Composition

Introduction

Calum B McFarlane is a notable inventor based in Linlithgow, GB. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on drug formulations. His expertise and dedication have led to the development of a unique pharmaceutical composition that enhances the delivery of essential medications.

Latest Patents

Calum holds a patent for a pharmaceutical composition containing nicardipine hydrochloride. This composition is designed for parenteral administration and includes a stable formulation with a non-chloride isotonicity agent, a buffering agent, and a pharmaceutically acceptable aqueous vehicle. This innovation is crucial for improving the stability and effectiveness of nicardipine in medical treatments.

Career Highlights

Calum has been associated with Syntex (U.S.A.) Inc., where he has applied his knowledge and skills to advance pharmaceutical research and development. His work has not only contributed to the company's portfolio but has also had a positive impact on patient care through improved drug formulations.

Collaborations

Throughout his career, Calum has collaborated with esteemed colleagues, including Alistair B Selkirk and Michael J Dey. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical industry.

Conclusion

Calum B McFarlane's contributions to pharmaceutical compositions exemplify the importance of innovation in healthcare. His work continues to influence the development of effective medications that benefit patients worldwide.